$is_valid_institution:
$is_valid_institution_group_access: no
$valid_institution_id:

Coverage for new medicines in public versus private drug plans in Canada.

Download Full Article Article Brief

Summary

Authors: Mark Rovere (Ph.D. candidate), Brett J Skinner (Ph.D.)

This study compares the quality of coverage for new drugs under public versus private drug plans in Canada. The focus of this study is important because there are proposals currently being advanced to replace private drug plans in Canada with a government-run monopoly public drug plan known as Pharmacare. Canadians might be surprised to find out how much better and faster coverage is under private drug plans compared to public drug plans. This report provides hard evidence from Canadian experience that pluralistic private competition among drug insurance plans and providers is good for patient choice and that a government-run Pharmacare monopoly will reduce access to new medicines.

Subscribe image

CHP blogazine

Opinions


Warning: Unknown: Your script possibly relies on a session side-effect which existed until PHP 4.2.3. Please be advised that the session extension does not consider global variables as a source of data, unless register_globals is enabled. You can disable this functionality and this warning by setting session.bug_compat_42 or session.bug_compat_warn to off, respectively. in Unknown on line 0